KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Receivables (2016 - 2026)

Encompass Health (EHC) has disclosed Receivables for 18 consecutive years, with $676.0 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables rose 8.44% year-over-year to $676.0 million; the TTM value through Mar 2026 reached $676.0 million, up 8.44%, while the annual FY2025 figure was $619.2 million, 3.41% up from the prior year.
  • Receivables hit $676.0 million in Q1 2026 for Encompass Health, up from $619.2 million in the prior quarter.
  • Across five years, Receivables topped out at $683.5 million in Q1 2022 and bottomed at $500.1 million in Q3 2022.
  • Average Receivables over 5 years is $594.1 million, with a median of $610.8 million recorded in 2025.
  • Year-over-year, Receivables dropped 24.73% in 2023 and then rose 20.37% in 2024.
  • Encompass Health's Receivables stood at $536.8 million in 2022, then grew by 13.93% to $611.6 million in 2023, then fell by 2.09% to $598.8 million in 2024, then increased by 3.41% to $619.2 million in 2025, then increased by 9.17% to $676.0 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $676.0 million, $619.2 million, and $610.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.